| Detected | Trial | Change |
|---|---|---|
| 2026-05-27 | NCT05340465 Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm… |
date change Primary completion pushed: 2026-10-30 -> 2027-01-30 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07537816 | Effects of Vadadustat on Anemia, Quality of Life, and Inflammation in Dialysis Patients | Renal Anemia | Not Yet Recruiting |
| Phase 3 | |||
| NCT06466785 | A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney… | Anemia of Chronic Kidney Disease | Recruiting |
| NCT06901505 | To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of… | Anemia of Chronic Kidney Disease | Active, Not Recruiting |
| NCT06520826 | Vafseo Outcomes In-Center Experience | Anemia of Chronic Kidney Disease | Active, Not Recruiting |
| Phase 2 | |||
| NCT05340465 | Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm… | Prematurity | Recruiting |
| Not specified | |||
| NCT07568574 | Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes | Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes | Enrolling by Invitation |